论文部分内容阅读
对于改变给药途径、剂量等给药特征的第二医药用途发明专利是否给予保护的问题已成为现阶段我国知识产权的争议焦点。目前,围绕着我国的立法理论、审查实践操作和国际立法借鉴等方面的论述较多。本文从我国医药产业的创新能力、诉讼状况、药品专利延期保护政策等角度,来分析现阶段第二医药用途发明专利的保护对我国医药产业的影响,希望我国立法者审时度势,在适合的时期,选择适当的保护形式,以促进医药产业稳定发展。
The question of whether the protection of the second medical use invention patent, such as the change of the administration route, dose and other administration features, has become the focus of controversy on intellectual property in China at this stage. At present, there are many expositions around the legislative theory of our country, the review of practical operation and the reference of international legislation. This article analyzes the impact of the protection of the second medical use invention patent on the pharmaceutical industry in our country from the perspectives of innovation ability, litigation status and drug patent deferred protection policy of our country, and hopes that the legislators in our country will review the situation and, at a suitable time, Select the appropriate form of protection to promote the stable development of the pharmaceutical industry.